Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroids

Objectives To investigate the long-term efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for multiple uterine fibroids and the factors associated with recurrence.Materials and methods Five hundred and forty-nine patients with multiple uterine fibroids treated with USgHIFU fr...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenjiang Lin, Feng Xu, Yuan Yuan, Jiaojiao Peng, Jin Luo, Chunmei Gong, Dayong Chen, Yangyang Wang, Donghong Wang, Bing Yang, Lian Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2024.2365388
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560884423426048
author Zhenjiang Lin
Feng Xu
Yuan Yuan
Jiaojiao Peng
Jin Luo
Chunmei Gong
Dayong Chen
Yangyang Wang
Donghong Wang
Bing Yang
Lian Zhang
author_facet Zhenjiang Lin
Feng Xu
Yuan Yuan
Jiaojiao Peng
Jin Luo
Chunmei Gong
Dayong Chen
Yangyang Wang
Donghong Wang
Bing Yang
Lian Zhang
author_sort Zhenjiang Lin
collection DOAJ
description Objectives To investigate the long-term efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for multiple uterine fibroids and the factors associated with recurrence.Materials and methods Five hundred and forty-nine patients with multiple uterine fibroids treated with USgHIFU from June 2017 to June 2019 were retrospectively analyzed. The Pictorial Blood Loss Assessment Chart (PBAC) was used to assess menstrual blood loss. The patients were asked to undergo pre- and post-USgHIFU magnetic resonance imaging (MRI) and complete routine follow-up after USgHIFU. Cox regression analysis was used to investigate the risk factors associated with recurrence.Results The median number of fibroids per patient was 3 (interquartile range: 3–4), and a total of 1371 fibroids were treated. Among them, 446 patients completed 3 years follow-up. Recurrence, defined as PBAC score above or equal to 100 and/or the residual fibroid volume increased by 10%, was detected in 90 patients within 3 years after USgHIFU, with a cumulative recurrence rate of 20.2% (90/446). The multi-factor Cox analysis showed that age was a protective factor for recurrence. Younger patients have a greater chance of recurrence than older patients. Mixed hyperintensity of fibroids on T2WI and treatment intensity were risk factors for recurrence. Patients with hyperintense uterine fibroids and treated with lower treatment intensity were more likely to experience recurrence than other patients after USgHIFU. No major adverse effects occurred.Conclusions USgHIFU can be used to treat multiple uterine fibroids safely and effectively. The age, T2WI signal intensity and treatment intensity are factors related to recurrence.
format Article
id doaj-art-3b7953cd0ef04749925188fb105e0eb1
institution Kabale University
issn 0265-6736
1464-5157
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj-art-3b7953cd0ef04749925188fb105e0eb12025-01-03T09:30:27ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572024-12-0141110.1080/02656736.2024.2365388Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroidsZhenjiang Lin0Feng Xu1Yuan Yuan2Jiaojiao Peng3Jin Luo4Chunmei Gong5Dayong Chen6Yangyang Wang7Donghong Wang8Bing Yang9Lian Zhang10State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, ChinaState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, ChinaState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, ChinaDepartment of Obstetrics and Gynaecology, Affiliated Hospital of Zunyi Medical University, Guizhou, ChinaDepartment of Obstetrics and Gynaecology, Affiliated Hospital of Zunyi Medical University, Guizhou, ChinaState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, ChinaState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, ChinaDepartment of Radiology, Chongqing Haifu Hospital, Chongqing, ChinaDepartment of Obstetrics and Gynaecology, Affiliated Hospital of Zunyi Medical University, Guizhou, ChinaDepartment of Obstetrics and Gynaecology, Affiliated Hospital of Zunyi Medical University, Guizhou, ChinaState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, ChinaObjectives To investigate the long-term efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for multiple uterine fibroids and the factors associated with recurrence.Materials and methods Five hundred and forty-nine patients with multiple uterine fibroids treated with USgHIFU from June 2017 to June 2019 were retrospectively analyzed. The Pictorial Blood Loss Assessment Chart (PBAC) was used to assess menstrual blood loss. The patients were asked to undergo pre- and post-USgHIFU magnetic resonance imaging (MRI) and complete routine follow-up after USgHIFU. Cox regression analysis was used to investigate the risk factors associated with recurrence.Results The median number of fibroids per patient was 3 (interquartile range: 3–4), and a total of 1371 fibroids were treated. Among them, 446 patients completed 3 years follow-up. Recurrence, defined as PBAC score above or equal to 100 and/or the residual fibroid volume increased by 10%, was detected in 90 patients within 3 years after USgHIFU, with a cumulative recurrence rate of 20.2% (90/446). The multi-factor Cox analysis showed that age was a protective factor for recurrence. Younger patients have a greater chance of recurrence than older patients. Mixed hyperintensity of fibroids on T2WI and treatment intensity were risk factors for recurrence. Patients with hyperintense uterine fibroids and treated with lower treatment intensity were more likely to experience recurrence than other patients after USgHIFU. No major adverse effects occurred.Conclusions USgHIFU can be used to treat multiple uterine fibroids safely and effectively. The age, T2WI signal intensity and treatment intensity are factors related to recurrence.https://www.tandfonline.com/doi/10.1080/02656736.2024.2365388High-intensity focused ultrasoundmultiple uterine fibroidslong-term resultsrecurrencere-intervention
spellingShingle Zhenjiang Lin
Feng Xu
Yuan Yuan
Jiaojiao Peng
Jin Luo
Chunmei Gong
Dayong Chen
Yangyang Wang
Donghong Wang
Bing Yang
Lian Zhang
Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroids
International Journal of Hyperthermia
High-intensity focused ultrasound
multiple uterine fibroids
long-term results
recurrence
re-intervention
title Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroids
title_full Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroids
title_fullStr Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroids
title_full_unstemmed Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroids
title_short Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroids
title_sort risk factors affecting long term efficacy of ultrasound guided high intensity focused ultrasound treatment for multiple uterine fibroids
topic High-intensity focused ultrasound
multiple uterine fibroids
long-term results
recurrence
re-intervention
url https://www.tandfonline.com/doi/10.1080/02656736.2024.2365388
work_keys_str_mv AT zhenjianglin riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT fengxu riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT yuanyuan riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT jiaojiaopeng riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT jinluo riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT chunmeigong riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT dayongchen riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT yangyangwang riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT donghongwang riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT bingyang riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids
AT lianzhang riskfactorsaffectinglongtermefficacyofultrasoundguidedhighintensityfocusedultrasoundtreatmentformultipleuterinefibroids